Jeet Mukherjee
Stock Analyst at BTIG
(4.37)
# 1,138
Out of 5,028 analysts
148
Total ratings
50%
Success rate
14.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VSTM Verastem | Reiterated: Buy | $18 | $8.00 | +125.00% | 7 | Oct 5, 2026 | |
| FHTX Foghorn Therapeutics | Downgraded: Hold | n/a | $2.00 | - | 6 | Oct 1, 2026 | |
| ORIC ORIC Pharmaceuticals | Initiated Coverage: Buy | $26 | $12.49 | +108.17% | 1 | Sep 23, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $125 | $29.28 | +326.91% | 6 | Sep 22, 2026 | |
| IPHA Innate Pharma | Reiterated: Buy | $9 | $1.58 | +469.62% | 7 | Sep 17, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | $55 | $27.10 | +102.95% | 6 | Sep 13, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $48 | $14.61 | +228.65% | 5 | Aug 20, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | n/a | $5.22 | - | 10 | Aug 12, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $42 | $28.46 | +47.58% | 4 | Aug 12, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $28 → $39 | $17.29 | +125.56% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 → $133 | $78.29 | +69.88% | 17 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.57 | +444.75% | 10 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $10.38 | +15.61% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $132.16 | +62.68% | 10 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $22.88 | +39.86% | 12 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 → $134 | $109.85 | +21.98% | 13 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $7.46 | +141.29% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.62 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $18.78 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.2953 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $45.47 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $16.54 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $38.07 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0005 | n/a | 1 | Apr 1, 2025 |
Verastem
Oct 5, 2026
Reiterated: Buy
Price Target: $18
Current: $8.00
Upside: +125.00%
Foghorn Therapeutics
Oct 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $2.00
Upside: -
ORIC Pharmaceuticals
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $12.49
Upside: +108.17%
Viking Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $125
Current: $29.28
Upside: +326.91%
Innate Pharma
Sep 17, 2026
Reiterated: Buy
Price Target: $9
Current: $1.58
Upside: +469.62%
Faeth Therapeutics
Sep 13, 2026
Reiterated: Buy
Price Target: $55
Current: $27.10
Upside: +102.95%
Ascentage Pharma Group International
Aug 20, 2026
Reiterated: Buy
Price Target: $48
Current: $14.61
Upside: +228.65%
Aardvark Therapeutics
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.22
Upside: -
ArriVent BioPharma
Aug 12, 2026
Reiterated: Buy
Price Target: $42
Current: $28.46
Upside: +47.58%
Bicara Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $28 → $39
Current: $17.29
Upside: +125.56%
Aug 12, 2026
Reiterated: Buy
Price Target: $117 → $133
Current: $78.29
Upside: +69.88%
Aug 11, 2026
Reiterated: Buy
Price Target: $14
Current: $2.57
Upside: +444.75%
Aug 4, 2026
Reiterated: Buy
Price Target: $12
Current: $10.38
Upside: +15.61%
Aug 4, 2026
Reiterated: Buy
Price Target: $215
Current: $132.16
Upside: +62.68%
Jul 1, 2026
Rated: Buy
Price Target: $32
Current: $22.88
Upside: +39.86%
Jun 25, 2026
Reiterated: Buy
Price Target: $138 → $134
Current: $109.85
Upside: +21.98%
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $7.46
Upside: +141.29%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.62
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $91
Current: $18.78
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $12
Current: $0.2953
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $45.47
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $100
Current: $16.54
Upside: n/a
Apr 14, 2025
Reiterated: Buy
Price Target: $62
Current: $38.07
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a